Company / Current Assets per Share
Amphstar Pharmaceuticals, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$13.36
FY2025
5-year range
$6.70 / $13.36
FY2021-FY2025
Trend
+20.2%
vs FY2024
Sector context
#51 of 210
Health Care
What the data says
Amphstar Pharmaceuticals, Inc.'s current assets per share of $13.36 is higher than 76% of companies in the Health Care sector (FY2025). Current Assets per Share has increased for 8 consecutive years, from $4.06 in FY2017 to $13.36 in FY2025.
Based on SEC 10-K filings.
13.36 in FY2025 with a 5-year CAGR of +17.3%. Top quartile in the Health Care sector.
Improved from $10.18 to $13.36 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +19.0%
- 5-Year CAGR
- +17.3%
- 10-Year CAGR
- -
Sector benchmark
-92.2% below sector average
Key checks
Key Insights
- Amphstar Pharmaceuticals, Inc.'s current assets per share has grown for 8 consecutive years.
- In FY2025, current assets per share increased 20.2% year-over-year.
- Ranks #51 out of 210 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.36 | +20.2% |
| FY2024 | $11.11 | +9.2% |
| FY2023 | $10.18 | +28.3% |
| FY2022 | $7.93 | +18.4% |
| FY2021 | $6.70 | +11.5% |
| FY2020 | $6.00 | +9.7% |
| FY2019 | $5.47 | +15.8% |
| FY2018 | $4.73 | +16.4% |
| FY2017 | $4.06 | -0.3% |
| FY2016 | $4.07 | +3.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026